Teleflex Incorporated
TFX
Peringkat dalam Saham
#3215
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Harga Saham
$131.01
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$5.55B
Perubahan (1 hari)
1.10%
Perubahan (1 tahun)
-1.54%
Negara
US
Perdagangan Teleflex Incorporated (TFX)
Kategori
Healthcare
Pendapatan untuk Teleflex Incorporated (TFX)
Pendapatan pada Jun 2026 TTM: $2.60B
Menurut laporan keuangan terbaru dari Teleflex Incorporated, pendapatan saat ini (TTM) adalah $2.60B. Pada tahun 2023, perusahaan menghasilkan pendapatan sebesar $2.97B peningkatan dibandingkan pendapatan pada tahun 2022 yang sebesar $2.79B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Teleflex Incorporated dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $2.60B | -14.66% |
| 2024 | $3.05B | 2.45% |
| 2023 | $2.97B | 6.57% |
| 2022 | $2.79B | -0.66% |
| 2021 | $2.81B | 10.74% |
| 2020 | $2.54B | -2.24% |
| 2019 | $2.60B | 6.00% |
| 2018 | $2.45B | 14.07% |
| 2017 | $2.15B | 14.90% |
| 2016 | $1.87B | 3.22% |
| 2015 | $1.81B | -1.64% |
| 2014 | $1.84B | 8.46% |
| 2013 | $1.70B | 9.37% |
| 2012 | $1.55B | 1.45% |
| 2011 | $1.53B | -15.14% |
| 2010 | $1.80B | -4.67% |
| 2009 | $1.89B | -21.93% |
| 2008 | $2.42B | 25.16% |
| 2007 | $1.93B | -26.92% |
| 2006 | $2.65B | 5.26% |
| 2005 | $2.51B | 1.17% |
| 2004 | $2.49B | 8.89% |
| 2003 | $2.28B | 9.93% |
| 2002 | $2.08B | 8.99% |
| 2001 | $1.91B | 7.96% |
| 2000 | $1.76B | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $11.03B | 324.30% |
US
|
|
| $34.74B | 1,235.71% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 701.32% |
US
|
|
| - | - |
CH
|
